NYSE · Healthcare
Envista Holdings Corp (NVST)
As-reported financials and recent SEC filings for Envista Holdings Corp, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.72B
Net income
$47.0M
Net margin
1.7%
Diluted EPS
$0.28
ROE
1.5%
P/E (TTM)
65.8×
Market cap
$4.39B
Debt / equity
0.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.72B | $2.51B | $2.57B | $2.57B | $2.51B |
| Gross profit | $1.49B | $1.37B | $1.44B | $1.47B | $1.43B |
| Operating income | $216.1M | $-1.04B | $31.5M | $319.2M | $306.2M |
| Net income | $47.0M | $-1.12B | $-100.2M | $243.1M | $340.5M |
| Diluted EPS | $0.28 | $-6.50 | $-0.60 | $1.37 | $1.92 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-03
View on EDGAR →SD2026-05-28
View on EDGAR →42026-05-27
View on EDGAR →42026-05-21
View on EDGAR →8-K2026-05-21
View on EDGAR →42026-05-21
View on EDGAR →42026-05-21
View on EDGAR →42026-05-21
View on EDGAR →Go deeper on NVST
Search Envista Holdings Corp’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.